ramucirumab - medicine shortage information
Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations
If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.
More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub
| Product details |
Supply Impact Dates |
Further Details |
CYRAMZA ramucirumab 100 mg/10 mL solution for intravenous infusion vial AUST R: 227351Active ingredients:
ramucirumab
Dosage form:
Injection, intravenous infusion
Sponsor:
Eli Lilly Australia Pty Ltd
Phone:
1800454559
|
From
23 Feb 2024
to
18 Mar 2024
|
Shortage status:
Resolved
Availability:
Available
Reason:
Manufacturing
|